ADHD Comorbidity Structure and Impairment: Results of the WHO World Mental Health Surveys International College Student Project (WMH-ICS).


Journal

Journal of attention disorders
ISSN: 1557-1246
Titre abrégé: J Atten Disord
Pays: United States
ID NLM: 9615686

Informations de publication

Date de publication:
06 2022
Historique:
pubmed: 11 11 2021
medline: 6 5 2022
entrez: 10 11 2021
Statut: ppublish

Résumé

To examine the prevalence of ADHD and the association of comorbid disorders, and multivariate disorder classes with role impairment in college students. About 15,991 freshmen (24 colleges, 9 countries, WMH-ICS) (response rate = 45.6%) completed online WMH-CIDI-SC surveys for 6-month ADHD and six 12-month DSM-IV disorders. We examined multivariate disorder classes using latent class analysis (LCA) and simulated a population attributable risk proportions (PARPs) of ADHD-related impairment. About 15.9% had ADHD, of which 58.4% had comorbidities. LCA classified ADHD respondents to pure (42.9%), internalizing (36.0%), bipolar comorbidities (11.3%), and externalizing disorder classes (9.8%). ADHD, comorbidities, and multivariate disorder classes independently predicted severe impairment. PARPs: eliminating ADHD hypothetically reduced severe impairment by 19.2%, 10.1% adjusted for comorbidities, 9.5% for multivariate disorder classes. ADHD and comorbid disorders are common and impairing in college students. Personalized transdiagnostic interventions guided by multivariate disorder classes should be explored.

Identifiants

pubmed: 34753324
doi: 10.1177/10870547211057275
pmc: PMC9064996
mid: NIHMS1785839
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1078-1096

Subventions

Organisme : NIMH NIH HHS
ID : R56 MH109566
Pays : United States
Organisme : NIMH NIH HHS
ID : R56 MH109566
Pays : United States

Références

Int J Methods Psychiatr Res. 2019 Jun;28(2):e1761
pubmed: 30614123
Mol Psychiatry. 2016 May;21(5):717-21
pubmed: 26303662
Atten Defic Hyperact Disord. 2017 Mar;9(1):47-65
pubmed: 27866355
Soc Psychiatry Psychiatr Epidemiol. 2018 Mar;53(3):279-288
pubmed: 29340781
Int J Methods Psychiatr Res. 2019 Jun;28(2):e1750
pubmed: 30402985
Ann Clin Psychiatry. 2012 Feb;24(1):23-37
pubmed: 22303520
Psychol Med. 1998 Jan;28(1):109-26
pubmed: 9483687
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
J Atten Disord. 2019 Dec;23(14):1736-1745
pubmed: 28992747
J Atten Disord. 2011 Nov;15(8):656-66
pubmed: 20679154
BMC Psychiatry. 2020 Apr 22;20(1):180
pubmed: 32321462
Int J Methods Psychiatr Res. 2008;17(1):45-54
pubmed: 18286465
Psychol Med. 2013 Aug;43(8):1625-37
pubmed: 23075829
J Atten Disord. 2006 Aug;10(1):9-19
pubmed: 16840588
J Clin Psychiatry. 2016 Apr;77(4):e421-8
pubmed: 27137426
World Psychiatry. 2021 Feb;20(1):57-63
pubmed: 33432749
Br J Psychiatry. 2008 May;192(5):368-75
pubmed: 18450663
BMC Psychiatry. 2017 Aug 22;17(1):302
pubmed: 28830387
Biometrics. 1993 Sep;49(3):865-72
pubmed: 8241375
Depress Anxiety. 2018 Sep;35(9):802-814
pubmed: 29847006
Int J Methods Psychiatr Res. 2019 Jun;28(2):e1764
pubmed: 30663193
BJPsych Bull. 2015 Jun;39(3):140-3
pubmed: 26191454
Psychol Med. 2013 Sep;43(9):1973-84
pubmed: 23298428
Appl Neuropsychol. 2007;14(3):189-207
pubmed: 17848130
Am J Psychiatry. 2007 Jun;164(6):942-8
pubmed: 17541055
J Learn Disabil. 2008 Jul-Aug;41(4):371-84
pubmed: 18560023
J Abnorm Psychol. 2018 Oct;127(7):623-638
pubmed: 30211576
Psychol Med. 2005 Feb;35(2):245-56
pubmed: 15841682
Lancet. 2020 Feb 8;395(10222):450-462
pubmed: 31982036
Int J Methods Psychiatr Res. 2007;16(2):52-65
pubmed: 17623385
J Atten Disord. 2008 Mar;11(5):558-67
pubmed: 18025248
J Clin Child Adolesc Psychol. 2018 Mar-Apr;47(2):236-247
pubmed: 26852645
Int J Methods Psychiatr Res. 2019 Jun;28(2):e1752
pubmed: 30450753
Int J Psychiatry Clin Pract. 2019 Nov;23(4):238-244
pubmed: 31232613
Stat Methods Med Res. 1996 Sep;5(3):283-310
pubmed: 8931197
Psychol Med. 2006 Feb;36(2):159-65
pubmed: 16420712
Int J Methods Psychiatr Res. 2004;13(2):93-121
pubmed: 15297906
J Atten Disord. 2009 Nov;13(3):234-50
pubmed: 19620623
J Clin Child Adolesc Psychol. 2021 Nov-Dec;50(6):828-843
pubmed: 33529049
Alcohol Clin Exp Res. 2002 Feb;26(2):272-9
pubmed: 11964568
Br J Psychiatry. 2016 Jun;208(6):548-55
pubmed: 26250744
J Psychiatr Res. 2012 Jun;46(6):782-9
pubmed: 22480749
J Atten Disord. 2020 Jan;24(1):126-135
pubmed: 30259782
Mol Psychiatry. 2019 Apr;24(4):562-575
pubmed: 29892054
Drug Alcohol Depend. 2013 Oct 1;132(3):587-96
pubmed: 23660242
J Atten Disord. 2008 May;11(6):677-88
pubmed: 18079307
Psychol Med. 2018 Mar;48(4):554-565
pubmed: 28805169
J Child Psychol Psychiatry. 2001 Oct;42(7):933-42
pubmed: 11693588
J Atten Disord. 2009 Nov;13(3):271-6
pubmed: 19429881
Eur Psychiatry. 2012 Jul;27(5):314-20
pubmed: 22112307
Int J Psychiatry Med. 1997;27(2):93-105
pubmed: 9565717
Lancet Psychiatry. 2016 Jun;3(6):568-78
pubmed: 27183901
Int J Methods Psychiatr Res. 2013 Dec;22(4):303-21
pubmed: 24318219
J Affect Disord. 2021 Jan 15;279:572-577
pubmed: 33152561
Depress Anxiety. 2017 Jul;34(7):596-602
pubmed: 28471479
J Atten Disord. 2019 Dec;23(14):1766-1779
pubmed: 26744315
J Learn Disabil. 2001 Jul-Aug;34(4):370-9
pubmed: 15503581
J Atten Disord. 2009 Nov;13(3):297-309
pubmed: 19474463
J Med Internet Res. 2019 Nov 1;21(11):e13478
pubmed: 31682573
J Child Psychol Psychiatry. 2020 Sep;61(9):1009-1018
pubmed: 31957030
Int J Methods Psychiatr Res. 2019 Jun;28(2):e1782
pubmed: 31069905
J Affect Disord. 2018 Dec 1;241:291-296
pubmed: 30142587
Suicide Life Threat Behav. 2009 Oct;39(5):548-57
pubmed: 19929154
Neurotherapeutics. 2012 Jul;9(3):559-68
pubmed: 22678459

Auteurs

Arthur D P Mak (ADP)

The Chinese University of Hong Kong, Tai Po, Hong Kong SAR.

Sue Lee (S)

Harvard Medical School, Boston, MA, USA.

Nancy A Sampson (NA)

Harvard Medical School, Boston, MA, USA.

Yesica Albor (Y)

Instituto Nacional de Psiquiatría Ramon de la Fuente Muñiz, Mexico City, Mexico.

Jordi Alonso (J)

IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain.
CIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Pompeu Fabra University (UPF), Barcelona, Spain.

Randy P Auerbach (RP)

Columbia University, New York, NY, USA.

Harald Baumeister (H)

Ulm University, Germany.

Corina Benjet (C)

Instituto Nacional de Psiquiatría Ramon de la Fuente Muñiz, Mexico City, Mexico.

Ronny Bruffaerts (R)

Universitair Psychiatrisch Centrum - Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Belgium.

Pim Cuijpers (P)

Vrije Universiteit Amsterdam, The Netherlands.

David D Ebert (DD)

Technical University Munich, Germany.

Raúl A Gutierrez-Garcia (RA)

De La Salle Bajio University, Salamanca, Guanajuato, Mexico.

Penelope Hasking (P)

Curtin University, Perth, WA, Australia.

Coral Lapsley (C)

Ulster University, Derry, UK.

Christine Lochner (C)

Stellenbosch University, South Africa.

Ronald C Kessler (RC)

Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH